Pluri Inc. Earnings Per Share (Diluted)
Pluri Inc. (PLUR) reported Earnings Per Share (Diluted) of -$2.44 per share for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-09-10
- Pluri Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.55.
- Pluri Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.55.
- Pluri Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.71.
- Pluri Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.65.
- Pluri Inc. earnings per share, diluted for fiscal 2026 was -$2.44.
- Pluri Inc. earnings per share, diluted for fiscal 2025 was -$3.56.
- Pluri Inc. earnings per share, diluted for fiscal 2024 was -$3.99.
- Pluri Inc. earnings per share, diluted for fiscal 2023 was -$6.24.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-09-10 | -$1.10 derived: net income ÷ weighted average shares · filed 2026-09-10 | -$1.80 derived: net income ÷ weighted average shares · filed 2026-09-10 | -$2.44 10-K · filed 2026-09-10 | ||||
| 2026-03-31 | -$0.55 10-Q · filed 2026-05-14 | -$1.25 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.90 10-Q · filed 2026-05-14 | -$2.83 derived: net income ÷ weighted average shares · filed 2026-09-10 | ||||
| 2025-12-31 | -$0.71 10-Q · filed 2026-02-12 | -$1.36 10-Q · filed 2026-02-12 | -$2.30 derived: net income ÷ weighted average shares · filed 2026-09-10 | -$3.21 derived: net income ÷ weighted average shares · filed 2026-09-10 | ||||
| 2025-09-30 | -$0.65 10-Q · filed 2025-11-12 | -$1.60 derived: net income ÷ weighted average shares · filed 2026-09-10 | -$2.52 derived: net income ÷ weighted average shares · filed 2026-09-10 | -$3.12 derived: net income ÷ weighted average shares · filed 2026-09-10 | ||||
| 2025-06-30 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-09-10 | -$1.92 derived: net income ÷ weighted average shares · filed 2026-09-10 | -$2.52 derived: net income ÷ weighted average shares · filed 2026-09-10 | -$3.56 10-K · filed 2026-09-10 | ||||
| 2025-03-31 | -$0.94 10-Q · filed 2026-05-14 | -$1.50 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$2.56 10-Q · filed 2026-05-14 | $3.75 derived: net income ÷ weighted average shares · filed 2026-05-14 | ||||
| 2024-12-31 | -$0.53 10-Q · filed 2026-02-12 | -$1.61 10-Q · filed 2026-02-12 | $5.06 derived: net income ÷ weighted average shares · filed 2026-04-23 | $4.14 derived: net income ÷ weighted average shares · filed 2026-04-23 | ||||
| 2024-09-30 | -$1.08 10-Q · filed 2025-11-12 | $5.65 derived: net income ÷ weighted average shares · filed 2026-04-23 | $4.73 derived: net income ÷ weighted average shares · filed 2026-04-23 | $3.84 derived: net income ÷ weighted average shares · filed 2026-04-23 | ||||
| 2024-06-30 | $6.79 derived: net income ÷ weighted average shares · filed 2026-04-23 | $5.89 derived: net income ÷ weighted average shares · filed 2026-04-23 | $5.00 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$3.99 10-K · filed 2025-09-17 | ||||
| 2024-03-31 | -$1.01 10-Q · filed 2025-05-13 | -$1.96 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$2.92 10-Q · filed 2025-05-13 | $6.88 derived: net income ÷ weighted average shares · filed 2026-04-23 | ||||
| 2023-12-31 | -$0.96 10-Q · filed 2025-02-11 | -$0.12 10-Q · filed 2024-02-12 | -$1.92 10-Q · filed 2025-02-11 | -$0.24 10-Q · filed 2024-02-12 | $7.92 derived: net income ÷ weighted average shares · filed 2026-04-23 | $6.50 derived: net income ÷ weighted average shares · filed 2026-04-23 | ||
| 2023-09-30 | -$0.96 10-Q · filed 2024-11-12 | -$0.12 10-Q · filed 2023-11-13 | $8.90 derived: net income ÷ weighted average shares · filed 2026-04-23 | $7.49 derived: net income ÷ weighted average shares · filed 2026-04-23 | $2.48 derived: net income ÷ weighted average shares · filed 2026-04-23 | |||
| 2023-06-30 | $9.91 derived: net income ÷ weighted average shares · filed 2026-04-23 | $8.53 derived: net income ÷ weighted average shares · filed 2026-04-23 | $2.43 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$6.24 10-K · filed 2024-09-18 | -$0.78 10-K · filed 2023-09-12 | |||
| 2023-03-31 | -$1.52 10-Q · filed 2024-05-09 | -$0.19 10-Q · filed 2023-05-09 | -$0.82 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$5.04 10-Q · filed 2024-05-09 | -$0.63 10-Q · filed 2023-05-09 | -$1.20 derived: net income ÷ weighted average shares · filed 2024-05-09 | ||
| 2022-12-31 | -$0.24 10-Q · filed 2024-02-12 | -$0.44 10-Q · filed 2024-02-12 | -$0.71 derived: net income ÷ weighted average shares · filed 2024-02-12 | -$1.02 derived: net income ÷ weighted average shares · filed 2024-02-12 | ||||
| 2022-09-30 | -$0.19 10-Q · filed 2023-11-13 | -$0.47 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.77 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.11 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2022-06-30 | -$0.28 derived: net income ÷ weighted average shares · filed 2023-09-12 | -$0.58 derived: net income ÷ weighted average shares · filed 2023-09-12 | -$0.92 derived: net income ÷ weighted average shares · filed 2023-09-12 | -$1.28 10-K · filed 2023-09-12 | ||||
| 2022-03-31 | -$0.31 10-Q · filed 2023-05-09 | -$0.65 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$1.00 10-Q · filed 2023-05-09 | |||||
| 2021-12-31 | -$0.34 10-Q · filed 2023-02-13 | -$0.70 10-Q · filed 2023-02-13 | ||||||
| 2021-09-30 | -$0.36 10-Q · filed 2022-11-10 | |||||||
| 2021-06-30 | -$1.77 10-K · filed 2022-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |